Document is current
Any future updates will be listed below
-
Authors
Hisamatsu, Tadakazu
Naganuma, Makoto
Pinton, Philippe
Takeno, Mitsuhiro https://orcid.org/0000-0002-9212-7046
-
Funding
Funding for this research was provided by:
Ferring Pharmaceuticals
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 24 November 2024
First Online: 6 December 2024
Declarations
:
: Tadakazu Hisamatsu received grant support from Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Mochida Pharmaceutical Co. Ltd., Boston Scientific Corporation, Kissei Pharmaceutical Co. Ltd; consulting fees from Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Nichi-Iko Pharmaceutical Co., Ltd., Eli Lilly, Gilead Sciences, Bristol Myers Squibb; and lecture fees from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc. Kissei Pharmaceutical Co. Ltd. Makoto Naganuma received grants from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, Kyorin Pharmaceutical Co., Ltd., Alfresa Pharma Corporation; and lecture fees from Tanabe Pharma Corporation, AbbVie GK, Takeda Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Janssen Pharmaceutical K.K., Gilead Sciences, Inc. EA Pharma Co., Ltd., and Mochida Pharmaceutical Co., Ltd. Philippe Pinton is employed by Ferring Pharmaceuticals, is a Board of Directors member at PharmaBiome and owns stocks of Takeda Pharmaceutical Co., Ltd. Mitsuhiro Takeno received consulting fees, speaking fees, and research grants from AbbVie GK, Amgen K. K., Asahi Kasei, Astellas Pharma Inc., Nippon Boehringer-Ingelheim Co., Ltd., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K. K., Mitsubishi Tanabe Pharma Corporation, Nippon Shinyaku, Novartis, Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Taisyo Pharma, UBC Japan, and Viatris.
